Research Article

Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study

Table 3

Survival outcomes in each cancer type.

Primary organ affectedNo. of PatientsMaleFemaleSurvived at least 1 yearSurvived at least 2 yearsSurvived at least 3 yearsSurvived at least 4 yearsSurvived at least 5 years

Stomach4222203424212016 (38.1%)
G. Bladder4021193225201815 (37.5%)
Pancreas4424203428272117 (38.64%)
Liver3217152622191714 (43.75%)